Convalescent Plasma Therapy Global Market Report 2025

Global Convalescent Plasma Therapy Market Report 2024

Convalescent Plasma Therapy Global Market Report 2025 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Market Size, Trends, And Global Forecast 2025-2034

Name: Convalescent Plasma Therapy Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Convalescent Plasma Therapy Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Convalescent Plasma Therapy Global Market Report 2025

Proud Members Of

What Is Covered Under Convalescent Plasma Therapy Market?

Convalescent plasma is plasma that has been collected from people who have recovered or are convalescing and contains antibodies against the infection-causing microorganism. It is used for the treatment of patients infected by the respective pathogen.

The main antibody types of convalescent plasma therapy are IgM, IgG, and IgA. Immunoglobulin A (IgA) is an antibody that is essential for mucous membrane immunological activity. The different applications include Prophylaxis, and treatment and are used in various sectors such as hospitals and clinics, laboratories, and research institutes.

Convalescent Plasma Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Convalescent Plasma Therapy Market Size 2025 And Growth Rate?

The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from $0.05 billion in 2024 to $0.06 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorization (eua), patient availability, clinician and public awareness.

What Is The Convalescent Plasma Therapy Market Growth Forecast?

The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.09 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to evolving pathogens, immunotherapies development, regulatory frameworks, global preparedness, public health initiatives. Major trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment, telemedicine and remote monitoring, research into long-term effects.

Book your 30 minutes free consultation with our research experts

How Is The Convalescent Plasma Therapy Market Segmented?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products

What Is Driving The Convalescent Plasma Therapy Market? Efficacy And Safety Propel The Convalescent Plasma Therapy Market

Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period. Convalescent plasma transfusion has been of interest in the historical period for the treatment of other infectious disease outbreaks such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2022, results of a study conducted by the Houston Methodist hospital, which aimed at evaluating safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe with no adverse events reported and is efficient with 76% recovery rate. In May 2020, a study published in the Journal of Medical Virology stated that with convalescent plasma therapy, the mortality rate may be reduced in critically ill patients, beneficial effects on clinical symptoms will be observed, and an increase in neutralizing antibody titers and disappearance of SARS-CoV-2 RNA will be observed. The safety and efficacy of the convalescent plasma therapy in COVID-19 patients will boost the global convalescent plasma therapy market growth.

What Is Driving The Convalescent Plasma Therapy Market? Increase In The Number Of Hospitals Is Fueling The Growth Of The Convalescent Plasma Therapy Market

The increase in the number of hospitals is expected to boost the growth of the convalescent plasma therapy market going forward. A hospital is a specialized medical facility designed to provide a wide range of healthcare services, including diagnosis, treatment, and care for patients with various medical conditions and illnesses. Increased hospital numbers often correlate with improved healthcare infrastructure. This, in turn, translates to better facilities for collecting, processing and administering convalescent plasma, thereby raising the quality of care. For instance, in September 2022, according to a report published by Public Health Scotland (PHS), a Scotland-based government agency, the average number of staffed beds for acute specialties in 2021/22 was 13,323, up 3.6% from the previous year (2020/21). Acute specialities' occupancy rate increased from 74.8% in 2020–21 to 84.2% in 2021/22. Therefore, the increase in the number of hospitals is driving the growth of the convalescent plasma therapy market.

Who Are The Major Players In The Global Convalescent Plasma Therapy Market?

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

What Are The Key Trends Of The Global Convalescent Plasma Therapy Market? Antibody-Based Therapies Uplift The Convalescent Plasma Therapy Market

The development of antibody-based immunotherapy as a potential therapeutic intervention for COVID-19 shows opportunities for the convalescent plasma therapy market. Convalescent plasma therapy utilizes the antibodies produced against coronavirus by the donor to improve the immunity of the recipient. Companies are initiating trials, collaborating and investing for antibody-based COVID-19 therapy. In August 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, entered into a collaboration with the Biomedical Advanced Research and Development Authority (BARDA), to aid with the next-generation COVID-19 monoclonal antibody therapy's clinical development, clinical manufacturing, and regulatory licensure processes for preventing SARS-CoV-2 infection. This collaboration is a part of Project NextGen, an effort by the U.S. Department of Health and Human Services (HHS) to create a pipeline of modern COVID-19 vaccines and therapies. In accordance with the project's structure, Regeneron will independently develop and suggest an antibody candidate, which BARDA and Regeneron will then assess and select for additional research, manufacturing, and regulatory efforts. As convalescent plasma therapy utilizes antibodies, the focus over antibody-based COVID-19 therapy is expected to boost the market growth.

What Are The Key Trends Of The Global Convalescent Plasma Therapy Market? Kamada Ltd. Advances Hyperimmune Globulin Therapy with CYTOGAM for High-Risk Transplant Patients

Major companies operating in the convalescent plasma therapy market are focusing on developing innovative solutions, such as hyperimmune globulin therapies, to enhance treatment efficacy and address challenges associated with standard plasma therapies. Hyperimmune Globulin Therapies refer to treatments that utilize plasma with a high concentration of specific antibodies, derived from individuals who have recovered from an infection, to provide targeted and potent immune support for patients. For instance, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant advancements regarding its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]), now commercially available in the U.S. following FDA approval for its manufacturing facility in Israel. At IDWeek 2023, new clinical data demonstrated a five-year survival benefit for high-risk CMV mismatch lung transplant patients receiving CYTOGAM. Additionally, Kamada has formed its first Scientific Advisory Board to enhance U.S. clinical programs for the product.

Regional Outlook For The Global Convalescent Plasma Therapy Market

North America was the largest region in the convalescent plasma therapy market in 2024. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the convalescent plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

What Defines the Convalescent Plasma Therapy Market?

The convalescent plasma therapy market includes revenue earned by IgD and IgE. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Convalescent Plasma Therapy Industry?

The convalescent plasma therapy market research report is one of a series of new reports from The Business Research Company that provides convalescent plasma therapy market statistics, including convalescent plasma therapy industry global market size, regional shares, competitors with a convalescent plasma therapy market share, detailed convalescent plasma therapy market segments, market trends and opportunities, and any further data you may need to thrive in the convalescent plasma therapy industry. This convalescent plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Convalescent Plasma Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$0.06 billion
Revenue Forecast In 2034	$0.09 billion
Growth Rate	CAGR of 13.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Antibody type: IgM, IgG, IgA 2) By Application: Prophylaxis, Treatment 3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes Subsegments: 1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products 2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products 3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Convalescent Plasma Therapy Market Characteristics

3. Convalescent Plasma Therapy Market Trends And Strategies

4. Convalescent Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Convalescent Plasma Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Convalescent Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Convalescent Plasma Therapy Market Growth Rate Analysis

5.4. Global Convalescent Plasma Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Convalescent Plasma Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Convalescent Plasma Therapy Total Addressable Market (TAM)

6. Convalescent Plasma Therapy Market Segmentation

6.1. Global Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunoglobulin M (IgM)

Immunoglobulin G (IgG)

Immunoglobulin A

6.2. Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prophylaxis

Treatment

6.3. Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Laboratories And Research Institutes

6.4. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early-Stage Infection Plasma

Acute Phase Plasma

Other IgM-Based Plasma Products

6.5. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High Titer IgG Plasma

Standard IgG Plasma

Other IgG-Based Plasma Products

6.6. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plasma Rich In IgA

Specific IgA Antibody Plasma

Other IgA-Based Plasma Products

7. Convalescent Plasma Therapy Market Regional And Country Analysis

7.1. Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Convalescent Plasma Therapy Market

8.1. Asia-Pacific Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Convalescent Plasma Therapy Market

9.1. China Convalescent Plasma Therapy Market Overview

9.2. China Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Convalescent Plasma Therapy Market

10.1. India Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Convalescent Plasma Therapy Market

11.1. Japan Convalescent Plasma Therapy Market Overview

11.2. Japan Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Convalescent Plasma Therapy Market

12.1. Australia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Convalescent Plasma Therapy Market

13.1. Indonesia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Convalescent Plasma Therapy Market

14.1. South Korea Convalescent Plasma Therapy Market Overview

14.2. South Korea Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Convalescent Plasma Therapy Market

15.1. Western Europe Convalescent Plasma Therapy Market Overview

15.2. Western Europe Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Convalescent Plasma Therapy Market

16.1. UK Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Convalescent Plasma Therapy Market

17.1. Germany Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Convalescent Plasma Therapy Market

18.1. France Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Convalescent Plasma Therapy Market

19.1. Italy Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Convalescent Plasma Therapy Market

20.1. Spain Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Convalescent Plasma Therapy Market

21.1. Eastern Europe Convalescent Plasma Therapy Market Overview

21.2. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Convalescent Plasma Therapy Market

22.1. Russia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Convalescent Plasma Therapy Market

23.1. North America Convalescent Plasma Therapy Market Overview

23.2. North America Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Convalescent Plasma Therapy Market

24.1. USA Convalescent Plasma Therapy Market Overview

24.2. USA Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Convalescent Plasma Therapy Market

25.1. Canada Convalescent Plasma Therapy Market Overview

25.2. Canada Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Convalescent Plasma Therapy Market

26.1. South America Convalescent Plasma Therapy Market Overview

26.2. South America Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Convalescent Plasma Therapy Market

27.1. Brazil Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Convalescent Plasma Therapy Market

28.1. Middle East Convalescent Plasma Therapy Market Overview

28.2. Middle East Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Convalescent Plasma Therapy Market

29.1. Africa Convalescent Plasma Therapy Market Overview

29.2. Africa Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Convalescent Plasma Therapy Market Competitive Landscape And Company Profiles

30.1. Convalescent Plasma Therapy Market Competitive Landscape

30.2. Convalescent Plasma Therapy Market Company Profiles

30.2.1. Bio Farma Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Hilton Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Biotest AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. BPL Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. LFB SA Overview, Products and Services, Strategy and Financial Analysis

31. Convalescent Plasma Therapy Market Other Major And Innovative Companies

31.1. Octapharma AG

31.2. CSL Behring LLC

31.3. Takeda Pharmaceutical Company Ltd.

31.4. Orthosera Kft.

31.5. ADMA Biologics Inc.

31.6. GC Biopharma Corp

31.7. Grifols S.A

31.8. Sanquin Plasma Products B.V.

31.9. America's Blood Centers

31.10. Blood Centers of America Inc.

31.11. Anthem Inc.

31.12. Laboratory Corporation of America Holdings

31.13. Cerus Corporation

31.14. Emergent BioSolutions Inc.

31.15. Kedrion Biopharma Inc.

32. Global Convalescent Plasma Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Convalescent Plasma Therapy Market

34. Recent Developments In The Convalescent Plasma Therapy Market

35. Convalescent Plasma Therapy Market High Potential Countries, Segments and Strategies

35.1 Convalescent Plasma Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Convalescent Plasma Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Convalescent Plasma Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Bio Farma Financial Performance

Table 78: Hilton Pharma Ltd. Financial Performance

Table 79: Biotest AG Financial Performance

Table 80: BPL Ltd. Financial Performance

Table 81: LFB SA Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Bio Farma Financial Performance

Figure 78: Hilton Pharma Ltd. Financial Performance

Figure 79: Biotest AG Financial Performance

Figure 80: BPL Ltd. Financial Performance

Figure 81: LFB SA Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Plasma Therapy Global Market Report 2025 – By Type (Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)), By Application (Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications), By End-Users (Hospitals & Clinics, Laboratories (Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Fractionation Global Market Report 2025 – By Product (Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors), By Application (Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology), By End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Porcine Plasma Feed Global Market Report 2025 – By Type (Powder, Grain, Other Types), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications), By End User (Farmers, Farming Organizations, Feed Additive Companies, Animal Feed For Pets) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cold Plasma Global Market Report 2025 – By Regime (Atmospheric Cold Plasma, Low-Pressure Cold Plasma ), By Technology (Remote Treatment, Direct Treatment, Electrode Contact ), By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By End Use Sector (Automotive, Electronics & Semiconductors, Food Processing & Packaging, Medical, Aerospace, Polymers & Plastics, Other End-User Sector) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Mycoplasma Testing Global Market Report 2025 – By Product (Instruments, Assay, Kits, and Reagents), By Technology (PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies), By Application (Cell line Testing, Virus Testing, End- of- Production Cell Testing), By End User (Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Radiotherapy Devices Global Market Report 2025 – By Product Type (External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices), By Application (Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications), By End Users (Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Convalescent Plasma Therapy market?

How will the Convalescent Plasma Therapy market drivers and restraints affect the market dynamics? What forces will shape the Convalescent Plasma Therapy industry going forward?

The Convalescent Plasma Therapy market major growth driver - Increase In The Number Of Hospitals Is Fueling The Growth Of The Convalescent Plasma Therapy Market. For further insights on the Convalescent Plasma Therapy market, request a sample here

What is the forecast market size or the forecast market value of the Convalescent Plasma Therapy market?

The Convalescent Plasma Therapy market size has grown strongly in recent years. The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from $0.05 billion in 2024 to $0.06 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorization (eua), patient availability, clinician and public awareness. The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.09 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to evolving pathogens, immunotherapies development, regulatory frameworks, global preparedness, public health initiatives. Major trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment, telemedicine and remote monitoring, research into long-term effects. For further insights on the Convalescent Plasma Therapy market, request a sample here

How is the Convalescent Plasma Therapy market segmented?

The convalescent plasma therapy market covered in this report is segmented –
1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes
Subsegments:
1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products
2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products
3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products For further insights on the Convalescent Plasma Therapy market, request a sample here

Which region has the largest share of the Convalescent Plasma Therapy market? What are the other regions covered in the report?

North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Convalescent Plasma Therapy market, request a sample here.

Who are the major players in the Convalescent Plasma Therapy market?

What are the key trends in the Convalescent Plasma Therapy market?

Major trends in the Convalescent Plasma Therapy market include Kamada Ltd. Advances Hyperimmune Globulin Therapy with CYTOGAM for High-Risk Transplant Patients. For further insights on the Convalescent Plasma Therapy market, request a sample here.

What are the major opportunities in the Convalescent Plasma Therapy market? What are the strategies for the Convalescent Plasma Therapy market?

For detailed insights on the major opportunities and strategies in the Convalescent Plasma Therapy market, request a sample here.

How does the Convalescent Plasma Therapy market relate to the overall economy and other similar markets?

For detailed insights on Convalescent Plasma Therapy's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Convalescent Plasma Therapy industry?

For detailed insights on the mergers and acquisitions in the Convalescent Plasma Therapy industry, request a sample here.

What are the key dynamics influencing the Convalescent Plasma Therapy market growth? SWOT analysis of the Convalescent Plasma Therapy market.

For detailed insights on the key dynamics influencing the Convalescent Plasma Therapy market growth and SWOT analysis of the Convalescent Plasma Therapy industry, request a sample here.